Tradestie Institutional Equity Comparison Engine
BGLC vs OIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BGLC Overall Edge
BGLC Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioNexus Gene Lab Corp Common stock (BGLC) driven by superior Growth & Margin while OIO counters with relative strength in Momentum & Technical. Fundamentally, BGLC trades at N/M Forward P/E with -88.2% operating margin (-96.6% YoY revenue) versus OIO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BGLC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BGLC N/M vs OIO N/M Fwd P/E
Growth & Margin Winner
BGLC
Op Margin -88.2% vs N/A ยท YoY -96.6% vs N/A
Momentum & Technical Winner
OIO
1Y -86.2% vs -56.5% ยท 52W Pos 1% vs 5%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BGLC
NASDAQ
BioNexus Gene Lab Corp Common stock
Services-Medical Laboratories
$0.71
-13.43% 1D
Market Cap
$2.4M
1M Return
-42.19%
1Y Return
-86.22%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 53.0
Fund 56.0
Flow 50.0
Mom 60.0
OIO
US Equity
OIO
Institutional Equity
$1.68
-1.38% 1D
Market Cap
N/A
1M Return
-6.86%
1Y Return
-56.45%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 22.0
Fund 37.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGLC -86.22%
OIO -56.45%
Spread: +10.99 pp (OIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGLC TTM Op. Margin: -88.2%
OIO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGLC vs OIO. Trailing 12-month operating profitability (BGLC -88.2% vs OIO N/A) and valuation multiples (BGLC N/M vs OIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGLC | OIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4M | N/A | Larger Scale | BGLC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -96.6% | N/A | Higher Growth | BGLC |
| Operating Margin (TTM) Profitability | -88.2% | N/A | Higher Margin | BGLC |
| Net Profit Margin Profitability | -82.4% | N/A | Higher Margin | BGLC |
| Return on Equity (ROE) Capital Efficiency | -33.7% | N/A | Higher ROE | BGLC |
| 52-Week Range Position Momentum | 1% ($1โ$5) | 5% ($1โ$8) | Stronger Trend | OIO |
| Beta / 30D Volatility Risk Regime | 1.33ฮฒ ยท 84% Vol | -0.14ฮฒ ยท 53% Vol | Lower Realized Risk | OIO |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 36.4 / 100 (SELL) | Higher Composite | BGLC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGLC vs OIO Buy Guide
BGLC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
OIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGLC nor OIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.